Magnetic Stimulation Therapy for Treating Vascular Depression

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of depression associated with small vascular lesions in the brain (vascular depression).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Iowa
• Collaborator: National Institute of Mental Health (NIMH)
• Treatments: Citalopram; Dexetimide

Criteria

Inclusion Criteria:

• DSM-IV diagnosis of unipolar major or minor depressive disorder

• Hamilton Depression Rating Scale score of at least 18

• Depression that is associated with cerebrovascular disease

• Failed at least 1 treatment for vascular depression